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Visual Impairment/Intracranial Pressure (VIIP) is a top human
spaceflight risk for which NASA does not currently have a proven
mitigation strategy. Thigh cuffs (Braslets) and lower body negative
pressure (LBNP; Chibis) devices have been or are currently being
evaluated as a means to reduce VIIP signs and symptoms, but
these methods alone may not provide sufficient relief of cephalic
venous congestion and VIIP symptoms. Additionally, current
LBNP devices are too large and cumbersome for their systematic
use as a countermeasure. Therefore, a novel approach is needed
that is easy to implement and provides specific relief of
symptoms. This investigation will evaluate an impedance
threshold device (ITD) as a VIIP countermeasure.
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Pilot data demonstrate substantial reductions in IJV cross
sectional area and in estimated ICP as measured by CCFP. Study
funding commenced in November 2015 with human subject testing
planned for spring 2016.
The investigation team recognizes that ITD use as a routine
countermeasure during spaceflight may not be particularly
comfortable in its current form and function. The purpose of the
planned work is to 1) use the ITD as a tool to further understand
VIIP, and 2) establish the effectiveness of this methodology before
embarking on more in-depth investigations that could optimize
acceptability to crewmembers as a countermeasure.
Posture Time
Upright (seated) 15 min
Supine 15 min
Upright, mask off (washout) 5 min
6º HDT 15 min
Upright, mask off (washout) 5 min
15 º HDT 15 min
15 º HDT, no data collection 30 min
15 º HDT 15 min
The ITD works by providing up to 7 cm H2O (~5 mmHg) resistance
to inspiratory air flow, effectively turning the thorax into a vacuum
pump upon each inhalation that lowers the intrathoracic pressure
(ITP) and facilitates venous return to the heart. The ITD is FDA-
approved and was developed to augment venous return to the
central circulation and increase cardiac output during
cardiopulmonary resuscitation (CPR) and in patients with
hypotension. While the effect of ITD on CPR survival outcomes is
controversial, the ITD’s ability to lower ITP with a concomitant
decrease in intracranial pressure (ICP) is well documented1. A
similar concept that creates negative ITP during exhalation
(intrathoracic pressure regulator; ITPR) decreased ICP in 16 of 20
patients with elevated ICP in a hospital pilot study2. ITP and
central venous pressure (CVP) have been shown to decrease in
microgravity3,4. However ITP drops more than CVP, indicating an
increased transmural CVP. This could explain the paradoxical
distention of jugular veins (JV) in microgravity despite lower
absolute CVP and also suggests that JV transmural pressure is
not dramatically elevated. Use of an ITD may lower JV pressure
enough to remove or relieve cephalic venous congestion.
During spaceflight experiments with Braslet thigh cuffs and
modified (open-glottis) Mueller maneuvers, Braslets alone reduced
cardiac preload but only reduced the internal JV (IJV) cross
sectional area by 23%. The addition of Mueller maneuvers resulted
in an IJV area reduction of 48%5. This project will test if ITD
essentially applies a Mueller maneuver with added negative ITP in
every respiratory cycle, acting to: 1) reduce venous congestion in
the neck and 2) potentially lower ICP. The expected mechanism of
action is that in microgravity (or an analog), blood is relocated
toward the heart from vasculature in the head and neck.
Once validated, the ITD would be an exceptionally easy
countermeasure to deploy and test on the ISS. Dosage could be
altered through 1) duration of application and 2) inspiratory
resistance set point. Effects could be additionally enhanced
through co-application with other countermeasures such as thigh
cuffs or LBNP.
SPECIFIC AIMS
Using a supine and head down tilt (HDT) model, this 
investigation will:
1. Determine if an ITD can reduce venous 
congestion in the head and neck
2. Determine if an ITD can reduce indicators of 
elevated intracranial pressure
Figure 1: ITD and face mask
Figure 2: Effect of ITD 
use on ITP and ICP in a 
porcine model (from 
Convertino et al.) 1
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The experimental approach is to use a battery of tests that are
currently being used to evaluate the effects of other interventions.
Healthy test subjects (n=15) will participate in two sessions, one
with an ITD and one with a sham ITD (placebo). Blood pH and pCO2
measures will be made immediately prior to and following each
session. Subjects will be evaluated in the seated and supine
positions as well as head down tilt (HDT) postures, including 6 and
15 degree HDT. Measures taken at each posture will include IJV
cross sectional area, IJV and carotid artery Doppler, measures of
cardiac preload, transcranial Doppler (TCD), optic nerve sheath
diameter (ONSD), superior ophthalmic vein (SOV) Doppler, optical
coherence tomography (OCT), cochlear and cerebral fluid pressure
analysis (CCFP), otoacoustic emissions (OAE), intraocular
pressure (IOP), facial soft tissue thickness and hyperemia, arterial
blood pressure, ECG, and heart rate.
PILOT RESULTS
Figure 3: Effect of ITD breathing on IJV
cross-sectional area in the supine
position. A: M-mode across the IJV
without ITD, B: B-mode (2D) image of the
IJV without ITD, C: M-mode across the IJV
with ITD, D: B-mode image of the IJV
without ITD. In panels A and C ECG is the
green trace and respiration in red.
Figure 5: Noninvasive indication
of ICP changes in response to
ITD breathing at different
postures. Tympanic Membrane
Displacement (TMD) values in
n=2 trials each panel. A: subjects
at 15° head up tilt (15HUT),
Supine, 15° head down tilt
(15HDT), and Supine with ITD
breathing (Supine+ITD). B:
subjects at 30° head up tilt
(30HUT), Supine, 15° head down
tilt (15HDT), and 15° head down
tilt with ITD breathing
(15HDT+ITD). Higher TMD
displacement values indicate
lower ICP.
Figure 4: Effect of ITD
breathing on Internal
Jugular Vein (IJV) time-
weighted cross sectional
area in different postures
(n=1). IJV cross sectional
area was time-averaged
over one full respiratory
cycle at 15° head up tilt
(15HUT), Supine, and 15°
head down tilt (15HDT),
each posture with and
without ITD breathing.
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